ORIGINAL RESEARCH published: 09 July 2018 doi: 10.3389/fimmu.2018.01532 Human Mast Cell Tryptase Is a Potential Treatment for Snakebite Edited by: Envenoming Across Multiple Snake Ulrich Blank, Institut National de la Santé Species et de la Recherche Médicale (INSERM), France Elizabeth Anderson1†, Kathrin Stavenhagen 2†, Daniel Kolarich 2†, Christian P. Sommerhoff 3, Reviewed by: Marcus Maurer 1 and Martin Metz 1* Nicolas Gaudenzio, Institut National de la Santé 1 Department of Dermatology and Allergy, Charité – Universitätsmedizin Berlin, Berlin, Germany, 2 Department of Biomolecular et de la Recherche Médicale Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany, 3 Institute of Laboratory Medicine, University (INSERM), France Hospital, Ludwig-Maximilians-University, Munich, Germany Axel Lorentz, University of Hohenheim, Germany Snake envenoming is a serious and neglected public health crisis that is responsible *Correspondence: for as many as 125,000 deaths per year, which is one of the reasons the World Health Martin Metz Organization has recently reinstated snakebite envenoming to its list of category A
[email protected] neglected tropical diseases. Here, we investigated the ability of human mast cell prote- †Present address: Elizabeth Anderson, ases to detoxify six venoms from a spectrum of phylogenetically distinct snakes. To this School of Medicine, UC end, we developed a zebrafish model to assess effects on the toxicity of the venoms San Diego, San Diego, CA, United States; and characterized the degradation of venom proteins by mass spectrometry. All snake Kathrin Stavenhagen, venoms tested were detoxified by degradation of various venom proteins by the mast Department of Surgery, cell protease tryptase , and not by other proteases.